A detailed history of National Bank Of Canada transactions in Merck & Co., Inc. stock. As of the latest transaction made, National Bank Of Canada holds 4,020,093 shares of MRK stock, worth $392 Million. This represents 0.63% of its overall portfolio holdings.

Number of Shares
4,020,093
Previous 4,020,093 -0.0%
Holding current value
$392 Million
Previous $457 Million -0.0%
% of portfolio
0.63%
Previous 0.63%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$111.15 - $128.97 $188 Million - $218 Million
1,689,212 Added 72.47%
4,020,093 $457 Million
Q2 2024

Aug 02, 2024

BUY
$123.8 - $132.96 $90.6 Million - $97.3 Million
731,741 Added 45.76%
2,330,881 $289 Million
Q1 2024

May 13, 2024

SELL
$113.24 - $131.95 $194 Million - $226 Million
-1,711,526 Reduced 51.7%
1,599,140 $211 Million
Q4 2023

Feb 06, 2024

BUY
$100.18 - $109.02 $104 Million - $113 Million
1,037,117 Added 45.62%
3,310,666 $361 Million
Q3 2023

Oct 10, 2023

BUY
$102.95 - $114.33 $127 Million - $141 Million
1,233,862 Added 118.68%
2,273,549 $234 Million
Q2 2023

Jul 26, 2023

BUY
$108.61 - $118.38 $11.2 Million - $12.2 Million
103,464 Added 11.05%
1,039,687 $120 Million
Q1 2023

Apr 12, 2023

SELL
$102.94 - $114.86 $53.3 Million - $59.4 Million
-517,494 Reduced 35.6%
936,223 $99.6 Million
Q4 2022

Jan 24, 2023

BUY
$87.44 - $112.11 $33.3 Million - $42.7 Million
380,784 Added 35.49%
1,453,717 $0
Q3 2022

Oct 13, 2022

BUY
$84.53 - $94.96 $44 Million - $49.5 Million
521,004 Added 94.4%
1,072,933 $92.5 Million
Q2 2022

Jul 28, 2022

SELL
$83.49 - $94.64 $16.3 Million - $18.5 Million
-195,280 Reduced 26.13%
551,929 $50.6 Million
Q1 2022

May 05, 2022

SELL
$73.51 - $82.4 $12.7 Million - $14.2 Million
-172,146 Reduced 18.72%
747,209 $62 Million
Q4 2021

Jan 24, 2022

BUY
$72.28 - $90.54 $66.5 Million - $83.2 Million
919,355 New
919,355 $70.5 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $247B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track National Bank Of Canada Portfolio

Follow National Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of National Bank Of Canada , based on Form 13F filings with the SEC.

News

Stay updated on National Bank Of Canada with notifications on news.